HeartMate 3 biventricular support exceeding 4.5 years
- PMID: 36896803
- PMCID: PMC10192271
- DOI: 10.1002/ehf2.14342
HeartMate 3 biventricular support exceeding 4.5 years
Abstract
A 47-year old male with ischaemic cardiomyopathy was referred to us for durable left ventricular assist device placement. He was found to have prohibitively elevated pulmonary vascular resistance for heart transplantation. He underwent HeartMate 3 left ventricular assist device implantation, with additional temporary right ventricular assist device (RVAD) placement. Following a 2-week period of unweanable temporary right ventricular support, the patient was switched to durable biventricular support with two Heartmate 3 pumps. The patient was placed on a transplant waiting list but was not offered a heart for over 4 years. While on Heartmate 3 biventricular support (BiVAD), he returned to full activity and enjoyed an excellent quality of life. He underwent laparoscopic cholecystectomy 7 months after the BIVAD implant. After 52 months of uneventful BiVAD support, he presented with a combination of adverse events that occurred over a short period. These included subarachnoidal haemorrhage and a new motor deficit, followed by RVAD infection and RVAD low-flow alarms. After over 4 years of unimpeded RVAD flows, new imaging revealed an outflow graft twist with subsequent flow reduction. The patient underwent heart transplantation after a total of 1655 days of Heartmate 3 BiVAD support and continues to do well on latest follow-up.
Keywords: HeartMate 3 BIVAD; Long-term biventricular support; Outcome.
© 2023 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Figures



References
-
- Frankfurter C, Molinero M, Vishram‐Nielsen JKK, Foroutan F, Mak S, Rao V, Billia F, Orchanian‐Cheff A, Alba AC. Predicting the risk of right ventricular failure in patients undergoing left ventricular assist device implantation: a systematic review. Circ Heart Fail 2020; 13: e006994. - PubMed
-
- Mehra MR, Uriel N, Naka Y, Cleveland JC Jr, Yuzefpolskaya M, Salerno CT, Walsh MN, Milano CA, Patel CB, Hutchins SW, Ransom J, Ewald GA, Itoh A, Raval NY, Silvestry SC, Cogswell R, John R, Bhimaraj A, Bruckner BA, Lowes BD, Um JY, Jeevanandam V, Sayer G, Mangi AA, Molina EJ, Sheikh F, Aaronson K, Pagani FD, Cotts WG, Tatooles AJ, Babu A, Chomsky D, Katz JN, Tessmann PB, Dean D, Krishnamoorthy A, Chuang J, Topuria I, Sood P, Goldstein DJ, MOMENTUM 3 Investigators . A fully magnetically levitated left ventricular assist device ‐ final report. N Engl J Med 2019; 380: 1618–1627. - PubMed
-
- Lavee J, Mulzer J, Krabatsch T, Marasco S, McGiffin D, Garbade J, Schmitto JD, Zimpfer D, Potapov EV. An international multicenter experience of biventricular support with HeartMate 3 ventricular assist systems. J Heart Lung Transplant 2018; 37: 1399–1402. - PubMed
-
- Aissaoui N, Morshuis M, Paluszkiewicz L, Lauenroth V, Börgermann J, Gummert J. Comparison of biventricular and left ventricular assist devices for the management of severe right ventricular dysfunction in patients with end‐stage heart failure. ASAIO J 2014; 60: 400–406. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical